INKKI peptide

General Information


DRACP ID  DRACP01103

Peptide Name   INKKI peptide

Sequence  INKKI

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  β-Casein

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=3.78 µg/mL MTT assay 24h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma IC50=3.53 μg/mL MTT assay 24h 1
T-47D Invasive breast carcinoma of no special type Carcinoma IC50=3.26 μg/mL MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=3.07 μg/mL MTT assay 24h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Fibroblast FN-1 (human): no effect (testing time is 24 h); Endothelial CRL 1730 (human) : no effect (testing time is 24 h)

Target  Not available

Affinity  Not available

Mechanism  By apoptosis via mitochondrial pathway in a caspase-independent manner

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01103

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C28H54N8O7

Absent amino acids  ACDEFGHLMPQRSTVWY

Common amino acids  IK

Mass  68632

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  2

Net charge  2

Boman Index  -790

Hydrophobicity  -46

Aliphatic Index  156

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Evaluation of the antitumor and antiproliferative effects of the INKKI peptide on MCF-7 breast adenocarcinoma cells

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.